Compare DOMH & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DOMH | SWZ |
|---|---|---|
| Founded | 1967 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 76.6M |
| IPO Year | 2010 | N/A |
| Metric | DOMH | SWZ |
|---|---|---|
| Price | $3.03 | $6.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.1K | ★ 66.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 21.52% | 6.59% |
| EPS Growth | ★ 39.75 | N/A |
| EPS | ★ 7.86 | N/A |
| Revenue | ★ $18,146,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.38 | ★ N/A |
| Revenue Growth | ★ 789.95 | N/A |
| 52 Week Low | $2.85 | $5.84 |
| 52 Week High | $8.40 | $9.43 |
| Indicator | DOMH | SWZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 50.82 |
| Support Level | $2.85 | $6.02 |
| Resistance Level | $3.56 | $6.10 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 31.80 | 51.43 |
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.